PARTICLE THERAPY MARKET ANALYSIS

Regional Analysis

Global Particle Therapy Market: Regional Analysis

North America is expected to hold dominant position in the global particle therapy market over the forecast period. The increasing prevalence of various types of cancers such as prostate cancer is one of the major factors driving growth of the particle therapy market in this region. For instance, in 2018, in the U.S, according to the American Cancer Society (ACS), 164,690 new cases of prostate cancer and over 29,430 related deaths were reported. In addition, according to the same source, around 60% of the prostate cancer patients (men) of 65 years or older were diagnosed in 2018, in the U.S. Also, one in every nine men is expected to be diagnosed with prostate cancer.

Asia Pacific is expected to exhibit highest CAGR over the forecast period due to rising number of patients suffering from cancer. For instance, according to the WHO, around 70% of deaths are due to cancer in developing countries of Asia Pacific region.

Increasing development of various cancer centers and proton therapy centers in the Asia Pacific region is expected propel Asia Pacific particle therapy market growth. For instance, in 2016, Shenzhen Hairong International Medical Development and Provision Asia entered into a joint venture to form Provision China and main objective of the company was to develop cancer center as well as proton center.